Navigation Links
Auxilium Pharmaceuticals Announces Results from Three Year CORDLESS Extension Study in Dupuytren's Contracture
Date:6/30/2011

by words such as "believe," "appears," "may," "could," "will," "estimate," "continue," "anticipate," "intend," "should," "plan," "expect," and other words and terms of similar meaning in connection with any discussion of projections, future performance or expectations, beliefs, plans or objectives for future operations (including statements of assumption underlying or relating to any of the foregoing). Actual results may differ materially from those reflected in these forward-looking statements due to various factors, including further evaluation of clinical data, results of clinical trials, decisions by regulatory authorities as to whether and when to approve drug applications, and general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries and those discussed in Auxilium's Annual Report under the heading "Risk Factors" on Form 10-K for the year ended December 31, 2010 and Form 10-Q for the quarter ended March 31, 2011, which are on file with the Securities and Exchange Commission (the "SEC") and may be accessed electronically by means of the SEC's home page on the Internet at http://www.sec.gov or by means of Auxilium's home page on the Internet at http://www.Auxilium.com under the heading "For Investors -- SEC Filings." There may be additional risks that Auxilium does not presently know or that Auxilium currently believes are immaterial which could also cause actual results to differ from those contained in the forward-looking statements. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements.

In addition, forward-looking statements provide Auxilium's expectations, plans or forecasts of future events and views as of the date of this release. Auxilium anticipates that subsequent events and d
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
3. BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
4. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
5. Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial Collagenase
6. Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference
7. Auxilium Pharmaceuticals Reports Preliminary Fourth Quarter 2010 Net Revenue and Announces 2011 XIAFLEX Revenue Guidance
8. Auxilium Pharmaceuticals to Present at the 2011 Citi Annual Global Healthcare Conference
9. Auxilium Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
10. Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX® Phase III Double-Blind Studies for Peyronies Disease
11. Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 23, 2014 Research and Markets ... "Emulsifiers - Global Strategic Business Report" report ... http://photos.prnewswire.com/prnh/20130307/600769 This report analyzes the ... US$ Thousands by the following Product Segments: Lecithin, ... and Sorbitan Esters, and Polyglycin Polyricinoleate & Others. ...
(Date:7/22/2014)... , July 23, 2014   ... Taiho Pharmaceutical Co., Ltd. (hereinafter "Taiho"), a fully-fledged ... company will be investing US$30 million in Remiges BioPharma ... capital fund. Taiho has a long history ... of oncologists and cancer patients. Our development of TAS-102 ...
(Date:7/22/2014)... July 22, 2014 /PRNewswire-iReach/ -- The global digital ... application, technology, portability, product, end user, price, and ... the highest growth rate in the digital X-ray ... high growth is attributed to technological advancements and ... accounted for the largest share of the digital ...
Breaking Medicine Technology:Emulsifiers - Global Strategic Business Report: Updated 2014 Report 2Emulsifiers - Global Strategic Business Report: Updated 2014 Report 3Taiho Pharmaceutical Invests US$30 Million in Remiges BioPharma Fund, LP 2Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 2Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 3Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 4Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 5
... the cholera outbreak continues to spread in ... is increasing its response in affected areas, pre-positioning much-needed ... in Port-au-Prince with critical, life-saving health and hygiene messages. ... this will take, we,re preparing for challenging weeks ahead," ...
... -- Sinovac Biotech Ltd. (Nasdaq: SVA ), ... today that it has been selected by the Beijing ... one of the five manufacturers to supply seasonal influenza ... part of the bidding process, the Beijing CDC evaluated ...
Cached Medicine Technology:As Cholera Outbreak Spreads, World Vision Deploys Teams to Distribute Emergency Health Supplies, Focus on Preventative Measures 2Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens 2Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens 3
(Date:7/23/2014)... 22, 2014) Mouse models of human oral cancer ... shrinkage without damage to surrounding tissues, researchers from the ... University of Texas Health Science Center at San Antonio ... on results of the study, which is described in ... diagnosis, low survival , Oral squamous cell carcinoma ...
(Date:7/23/2014)... 23, 2014 Follow us ... substances exclusively developed and manufactured for use in ... body tissues. These materials are biosafe with significantly ... Global market for biocompatible materials is expected to ... technological advancements and growing base of aging population ...
(Date:7/23/2014)... July 23, 2014 VogueQueen.com, a reliable ... than ever, hopes to help all clients to get ... online shopping popular in the market. This is why ... business. , Among thousands of online dress suppliers, ... has announced a new collection of fashionable hair ...
(Date:7/23/2014)... Relias Learning, the leader in SaaS-based ... services markets, continued to expand its market presence in ... its core markets and further expansion in new markets. ... SaaS-based training solutions accelerate across a wide range of ... and human services organizations, in particular, are seeing the ...
(Date:7/23/2014)... Fla. (PRWEB) July 23, 2014 FCCI ... Fit-Friendly Worksite by the American Heart Association for helping ... recognized as a Platinum-Level Fit-Friendly Worksite in 2013, 2011, ... 2012. , “FCCI makes employee health and wellness an ... and helping employees stay at the top of their ...
Breaking Medicine News(10 mins):Health News:Anti-pain agent shrinks oral cancers, leaves healthy tissues alone 2Health News:Surge in R&D Investments to Drive the Global Biocompatible Materials Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Surge in R&D Investments to Drive the Global Biocompatible Materials Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Reliable Online Supplier VogueQueen.com Helps Worldwide Ladies To Find Suitable Hair Wigs And Special Occasion Gowns 2Health News:Relias Learning announces Q2 results - continues record growth and new market expansion 2Health News:FCCI Insurance Group Recognized as an American Heart Association Fit-Friendly Worksite 2Health News:FCCI Insurance Group Recognized as an American Heart Association Fit-Friendly Worksite 3
... , SCHAUMBURG, Ill., July 29 ... Agency for Research on Cancer (IARC) for its re-categorization of ... indoor tanning in the highest cancer risk category afforded by ... Health Organization (WHO). , , "The ...
... of serious complications 4.3 percent, , WEDNESDAY, July 29 ... combat significant obesity, a new study suggests the risk ... previously been reported. , The study, which looked at ... (lap-band surgery), found that the risk of death for ...
... American Association for ... ... Cancer Prevention Research , a journal of the American Association for Cancer Research, suggests ... and neck. Furthermore, African Americans had far less HPV infection than whites, which led to ...
... , , ST. LOUIS, July ... second quarter net income from continuing operations of $192.0 million, or ... primarily related to the previously announced acquisition of WellPoint,s pharmacy benefit ... from $0.76 for the same period last year. These earnings for ...
... , , PRINCETON, N.J., July ... today reported GAAP earnings for its second quarter ended June 30, ... share gain related to the sale of its centralized ECG business ... diluted share. , , "On a consolidated basis, ...
... , , SAN DIEGO, July 29 ... company focused on developing products for minimally disruptive surgical treatments for ... and Investor Relations, is scheduled to present at the BMO Capital ... New York, New York, on Wednesday, August 5, 2009, at 11:15 ...
Cached Medicine News:Health News:American Academy of Dermatology Commends Reclassification of Tanning Beds as Carcinogenic 2Health News:American Academy of Dermatology Commends Reclassification of Tanning Beds as Carcinogenic 3Health News:Study Finds Weight-Loss Surgery Safer Than Thought 2Health News:Study Finds Weight-Loss Surgery Safer Than Thought 3Health News:HPV Infection May Be Linked to Poor Head and Neck Cancer Survival Rates in African Americans 2Health News:HPV Infection May Be Linked to Poor Head and Neck Cancer Survival Rates in African Americans 3Health News:HPV Infection May Be Linked to Poor Head and Neck Cancer Survival Rates in African Americans 4Health News:Express Scripts Reports Strong Second Quarter Earnings 2Health News:Express Scripts Reports Strong Second Quarter Earnings 3Health News:Express Scripts Reports Strong Second Quarter Earnings 4Health News:Express Scripts Reports Strong Second Quarter Earnings 5Health News:Express Scripts Reports Strong Second Quarter Earnings 6Health News:Express Scripts Reports Strong Second Quarter Earnings 7Health News:Express Scripts Reports Strong Second Quarter Earnings 8Health News:Express Scripts Reports Strong Second Quarter Earnings 9Health News:Express Scripts Reports Strong Second Quarter Earnings 10Health News:Express Scripts Reports Strong Second Quarter Earnings 11Health News:Express Scripts Reports Strong Second Quarter Earnings 12Health News:Express Scripts Reports Strong Second Quarter Earnings 13Health News:Express Scripts Reports Strong Second Quarter Earnings 14Health News:Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 2Health News:Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 3Health News:Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 4Health News:Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 5Health News:Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 6Health News:Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 7Health News:Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 8Health News:Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 9Health News:Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 10Health News:Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 11Health News:Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 12Health News:Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 13Health News:NuVasive to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference 2Health News:NuVasive to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference 3
Floor stand stabilizer system...
The robust, easy to maneuver floor-mounted stepper/stabilizer, offers strength and stability that has made this unit one of the most widely accepted floor fixation devices in the industry....
... of a welded titanium capsule containing either ... beads. The capsule body also contains ... x-ray markers to identify the source location ... non-sterile when shipped and must be sterilized ...
A Powerful New Quantitative Immunoassay for Monitoring Bladder Cancer Patients. Useful in Monitoring Patients for,Disease Progression and Recurrence....
Medicine Products: